SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-20-136837
Filing Date
2020-12-17
Accepted
2020-12-17 16:05:31
Documents
2
Period of Report
2020-12-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038774-1_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2038774-1_3aseq1.xml 3/A 3568
2 EXHIBIT 24 tm2038774d1_ex24.htm EX-24 7373
  Complete submission text file 0001104659-20-136837.txt   12395
Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Gallagher Carol Giltner (Reporting) CIK: 0001329959 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39765 | Film No.: 201396159

Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Issuer) CIK: 0001828326 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks